SUSANNAH GRAY - 26 Feb 2023 Form 3 Insider Report for Theravance Biopharma, Inc. (TBPH)

Role
Director
Signature
/s/ Brett A. Grimaud, Attorney-in-Fact
Issuer symbol
TBPH
Transactions as of
26 Feb 2023
Net transactions value
$0
Form type
3
Filing time
28 Feb 2023, 19:14:03 UTC
Previous filing
10 Jun 2022
Next filing
04 May 2023

No securities are beneficially owned.